Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Rash/Extensive localized hot rash in arm which had vaccine; This is a spontaneous report from a contactable consumer received from the Regulatory Authority (RA). The regulatory authority report number is GB-MHRA-WEBCOVID-202106030015356830-DV2QL, Safety Report Unique Identifier GB-MHRA-ADR 25408985. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EW3143), via an unspecified route of administration, administered in the arm on 01Jun2021 as 1st dose, single dose for COVID-19 immunization. The patient''s medical history and concomitant medications were not reported. Patient has not had symptoms associated with COVID-19. Patient is not enrolled in clinical trial. The patient experienced rash/extensive localized hot rash in arm which had vaccine on 01Jun2021. The reporter assessed the event as serious (medically significant). Patient has not tested positive for COVID-19 since having the vaccine. The patient underwent lab tests and procedures which included COVID-19 virus test: no/negative COVID-19 test on an unspecified date. The outcome of the event was not recovered. This report does not relate to possible blood clots or low platelet counts. No follow-up attempts are needed. No further information is expected.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166